Drugs Information:
Somapacitan
Basic Information
|
||
| ID | DDInter1698 | |
| Drug Type | biotech | |
| Protein Chemical Formula | C1038H1609N273O319S9 | |
| Protein Average Weight | - | |
| CAS Number | 1338578-34-9 | |
| Description | Somapacitan, also known as NNC0195-0092,[A219136] is a growth hormone analog indicated to treat adults with growth hormone deficiency.[A219126,L15661] This human growth hormone analog differs by the creation of an albumin binding site, and prolonging the effect so that it requires weekly dosing rather than daily.[A219146] Somapacitan was granted FDA approval on 28 August 2020.[L15666] | |
| ATC Classification | H01AC07 | |
| Sequences | None | |
| Useful Links | DrugBank KEGG Drug Wikipedia | |
Interactions with
Somapacitan
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|